AU2060897A - Murine alpha(1,3)fucosyltransferase fuc-tvii, dna encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such dna, and cells containing such plasmid - Google Patents

Murine alpha(1,3)fucosyltransferase fuc-tvii, dna encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such dna, and cells containing such plasmid

Info

Publication number
AU2060897A
AU2060897A AU20608/97A AU2060897A AU2060897A AU 2060897 A AU2060897 A AU 2060897A AU 20608/97 A AU20608/97 A AU 20608/97A AU 2060897 A AU2060897 A AU 2060897A AU 2060897 A AU2060897 A AU 2060897A
Authority
AU
Australia
Prior art keywords
same
dna
tvii
immunoassays
plasmid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU20608/97A
Other versions
AU731261B2 (en
Inventor
Kevin M. Gersten
John B Lowe
Shunji Natsuka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Publication of AU2060897A publication Critical patent/AU2060897A/en
Application granted granted Critical
Publication of AU731261B2 publication Critical patent/AU731261B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A gene which encodes a murine leukocyte α(1,3)fucosyltransferase capable of synthesizing the sialyl Lewis x determinant has been cloned.
AU20608/97A 1996-03-08 1997-03-07 Murine alpha(1,3)fucosyltransferase Fuc-TVII, DNA encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such DNA, and cells containing such plasmid Ceased AU731261B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61309896A 1996-03-08 1996-03-08
US08/613098 1996-03-08
PCT/US1997/003184 WO1997032889A1 (en) 1996-03-08 1997-03-07 MURINE α(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID

Publications (2)

Publication Number Publication Date
AU2060897A true AU2060897A (en) 1997-09-22
AU731261B2 AU731261B2 (en) 2001-03-29

Family

ID=24455853

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20608/97A Ceased AU731261B2 (en) 1996-03-08 1997-03-07 Murine alpha(1,3)fucosyltransferase Fuc-TVII, DNA encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such DNA, and cells containing such plasmid

Country Status (7)

Country Link
US (2) US6693183B2 (en)
EP (1) EP0888377B1 (en)
JP (1) JP2000507095A (en)
AT (1) ATE380820T1 (en)
AU (1) AU731261B2 (en)
DE (1) DE69738368T2 (en)
WO (1) WO1997032889A1 (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858752A (en) * 1995-06-07 1999-01-12 The General Hospital Corporation Fucosyltransferase genes and uses thereof
US6071732A (en) * 1998-01-29 2000-06-06 The Board Of Regents Of The University Of Oklahoma Tyrosylprotein sulfotransferases, nucleic acids encoding tyrosylprotein sulfotransferases, and methods of use thereof
US6207432B1 (en) 1998-01-29 2001-03-27 The Board Of Regents Of The University Of Oklahoma Tyrosylprotein sulfotransferases and methods of use thereof
US6713283B2 (en) 1998-01-29 2004-03-30 The Board Of Regents Of The University Of Oklahoma Tyrosylprotein sulfotransferases
US6060295A (en) * 1998-01-29 2000-05-09 The Board Of Regents Of The University Of Oklahoma Nucleic acids and expression systems encoding tyrosylprotein sulfo transferases
US7029890B2 (en) 1998-01-29 2006-04-18 Siwa Biotech Corporation Tyrosylprotein sulfotransferases and methods of use thereof
US6204016B1 (en) 1998-01-29 2001-03-20 The Board Of Regents Of The University Of Oklahoma Tyrosylprotein sulfotransferases and methods of use thereof
US6605455B1 (en) 1998-01-29 2003-08-12 The Board Of Regsnts Of The University Of Oklahoma Tyrosylprotein sulfotransferases and methods of use thereof
AU2957199A (en) * 1998-03-24 1999-10-18 Kyowa Hakko Kogyo Co. Ltd. Antibody against human alpha1,3-fucose transferase fuc-tvii
HUP0302299A2 (en) * 2000-05-12 2003-10-28 Neose Technologies, Inc. In vitro fucosylation recombinant glycopeptides
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7173003B2 (en) * 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
MXPA04012496A (en) * 2002-06-21 2005-09-12 Novo Nordisk Healthcare Ag Pegylated factor vii glycoforms.
BRPI0408358A (en) * 2003-03-14 2006-03-21 Neose Technologies Inc branched water-soluble polymers and their conjugates
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
MXPA05010773A (en) 2003-04-09 2005-12-12 Neose Technologies Inc Glycopegylation methods and proteins/peptides produced by the methods.
BRPI0410164A (en) * 2003-05-09 2006-05-16 Neose Technologies Inc compositions and methods for preparing human growth hormone glycosylation mutants
WO2005012484A2 (en) * 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) * 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
US20070254836A1 (en) * 2003-12-03 2007-11-01 Defrees Shawn Glycopegylated Granulocyte Colony Stimulating Factor
CN101072789B (en) * 2004-01-08 2013-05-15 生物种属学股份公司 O-linked glycosylation of peptides
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
US20090292110A1 (en) * 2004-07-23 2009-11-26 Defrees Shawn Enzymatic modification of glycopeptides
WO2006031811A2 (en) * 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
JP5948627B2 (en) 2004-10-29 2016-07-20 レイショファーム ゲーエムベーハー Fibroblast growth factor (FGF) remodeling and carbohydrate pegylation
EP1858543B1 (en) * 2005-01-10 2013-11-27 BioGeneriX AG Glycopegylated granulocyte colony stimulating factor
EP2386571B1 (en) 2005-04-08 2016-06-01 ratiopharm GmbH Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20110003744A1 (en) * 2005-05-25 2011-01-06 Novo Nordisk A/S Glycopegylated Erythropoietin Formulations
EP2975135A1 (en) 2005-05-25 2016-01-20 Novo Nordisk A/S Glycopegylated factor IX
FI20055398A0 (en) 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Method for evaluating cell populations
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
US9187532B2 (en) * 2006-07-21 2015-11-17 Novo Nordisk A/S Glycosylation of peptides via O-linked glycosylation sequences
JP2010505874A (en) * 2006-10-03 2010-02-25 ノヴォ ノルディスク アー／エス Purification method for polypeptide conjugates
CN101600448B (en) * 2006-10-04 2015-11-25 诺和诺德公司 The sugar of the PEGization that glycerol connects and glycopeptide
KR20150064246A (en) * 2007-04-03 2015-06-10 바이오제너릭스 게엠베하 Methods of treatment using glycopegylated g―csf
WO2008151258A2 (en) * 2007-06-04 2008-12-11 Neose Technologies, Inc. O-linked glycosylation using n-acetylglucosaminyl transferases
CA2690611C (en) * 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
US8207112B2 (en) * 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
US20100286067A1 (en) * 2008-01-08 2010-11-11 Biogenerix Ag Glycoconjugation of polypeptides using oligosaccharyltransferases
WO2009108806A1 (en) 2008-02-27 2009-09-03 Novo Nordisk A/S Conjugated factor viii molecules
EP2166085A1 (en) 2008-07-16 2010-03-24 Suomen Punainen Risti Veripalvelu Divalent modified cells
SG10201404280XA (en) * 2009-07-21 2014-10-30 Abt Holding Co Use of stem cells to reduce leukocyte extravasation
EP2456860B1 (en) * 2009-07-21 2018-09-05 ABT Holding Company Use of stem cells to reduce leukocyte extravasation
US9692789B2 (en) 2013-12-13 2017-06-27 Oracle International Corporation Techniques for cloud security monitoring and threat intelligence
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0643132B1 (en) * 1993-03-29 2006-05-31 Kyowa Hakko Kogyo Co., Ltd. Alpha-1,3-fucosyltransferase
US5858752A (en) * 1995-06-07 1999-01-12 The General Hospital Corporation Fucosyltransferase genes and uses thereof
US5858750A (en) * 1997-11-25 1999-01-12 Incyte Pharmaceuticals, Inc. Human retinol dehydrogenase type II homolog

Also Published As

Publication number Publication date
WO1997032889A1 (en) 1997-09-12
EP0888377B1 (en) 2007-12-12
EP0888377A1 (en) 1999-01-07
US20040063178A1 (en) 2004-04-01
EP0888377A4 (en) 2001-12-05
DE69738368T2 (en) 2008-12-04
US7723080B2 (en) 2010-05-25
AU731261B2 (en) 2001-03-29
US20020111469A1 (en) 2002-08-15
US6693183B2 (en) 2004-02-17
ATE380820T1 (en) 2007-12-15
JP2000507095A (en) 2000-06-13
DE69738368D1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
AU2060897A (en) Murine alpha(1,3)fucosyltransferase fuc-tvii, dna encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such dna, and cells containing such plasmid
EP0330191A3 (en) DNA encoding CD40
EP0833834A4 (en) Dna sequence and encoded mammary-specific breast cancer protein
AU6663294A (en) Cloned dna encoding a udp-galnac:polypeptide,n-acetylgalactos aminyltransferase
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
AU8635391A (en) Nucleotide sequences coding for a human protein with angiogenesis regulative properties
MX9708791A (en) Ataxia-telangiectasia gene and its genomic organization.
EP1375515A3 (en) Polypeptide, cDNA encoding the same, and use thereof
CA2131703A1 (en) Compositions and methods for the identification and synthesis of sialyltransferases
NZ331176A (en) Receptor protein designated 2F1, DNA encoding 2F1, preparation and use thereof
PL359863A1 (en) Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
AU577810B2 (en) Cloning the gene for rabbit tumor necrosis factor polypeptide
WO2000015798A3 (en) Mammalian transforming growth factor beta - 9 (ztgfss9)
EP0733709A3 (en) Mutated farnesyldiphosphate synthase capable of synthesizing geranylgeranyldiphosphate and gene coding therefor
AU4823993A (en) Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof
NZ319160A (en) An adhesin gene from helicobacter pylori, polypeptide coded thereby, vectors, cells, antibodies and immunogenic compositions
AU2085195A (en) Gene coding for igg-fc-binding protein
WO1990012098A3 (en) Methods and nucleic acid sequences for the expression of the cellulose synthase operon
WO2000020450A3 (en) Calcium channel alpha-2/delta gene
EP0341674A3 (en) Cloned tryptophan synthase gene and recombinant plasmid containing the same
AU3931599A (en) Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses
EP1026237A3 (en) Tau/neurofilament protein kinases pk40 & pk36
CA2187386A1 (en) Gene encoding endo-.beta.-n-acetylglucosaminidase a
CA2247966A1 (en) Murine .alpha.(1,3)fucosyltransferase fuc-tvii, dna encoding the same and uses thereof
DE69637429D1 (en) GENE ENCODING POLYPEPTIDE FOR LYMPHOCYTE SPECIFIC INTERFERON REGULATION FACTOR (LSIRF)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)